109 related articles for article (PubMed ID: 35715904)
1. Construction of a New Dual-Responsive Nano-Drug Delivery System for Matrix Metalloproteinases and Adenosine Triphosphate in Ovarian Cancer Using Nanomicelles.
Li G; Xu W; Shi Y; Chen M; Peng D
J Biomed Nanotechnol; 2022 Mar; 18(3):718-728. PubMed ID: 35715904
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
[TBL] [Abstract][Full Text] [Related]
3. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
4. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
[TBL] [Abstract][Full Text] [Related]
5. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
6. pH and GSH dual-responsive drug-controlled nanomicelles for breast cancer treatment.
Xu J; Tang X; Yang X; Zhao MX
Biomed Mater; 2023 Feb; 18(2):. PubMed ID: 36720160
[TBL] [Abstract][Full Text] [Related]
7. Reduction-sensitive micelles with sheddable PEG shells self-assembled from a Y-shaped amphiphilic polymer for intracellular doxorubicine release.
Cui C; Yu P; Wu M; Zhang Y; Liu L; Wu B; Wang CX; Zhuo RX; Huang SW
Colloids Surf B Biointerfaces; 2015 May; 129():137-45. PubMed ID: 25843367
[TBL] [Abstract][Full Text] [Related]
8. Star-shape redox-responsive PEG-sheddable copolymer of disulfide-linked polyethylene glycol-lysine-di-tocopherol succinate for tumor-triggering intracellular doxorubicin rapid release: head-to-head comparison.
Ai X; Sun J; Zhong L; Wu C; Niu H; Xu T; Lian H; Han X; Ren G; Ding W; Wang J; Pu X; He Z
Macromol Biosci; 2014 Oct; 14(10):1415-28. PubMed ID: 24948160
[TBL] [Abstract][Full Text] [Related]
9. Preparation of polyethylene glycol-polyacrylic acid block copolymer micelles with pH/hypoxic dual-responsive for tumor chemoradiotherapy.
Weng J; Huang Z; Pu X; Chen X; Yin G; Tian Y; Song Y
Colloids Surf B Biointerfaces; 2020 Jul; 191():110943. PubMed ID: 32203861
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer.
Gao X; Wang B; Wei X; Rao W; Ai F; Zhao F; Men K; Yang B; Liu X; Huang M; Gou M; Qian Z; Huang N; Wei Y
Int J Nanomedicine; 2013; 8():971-82. PubMed ID: 23493403
[TBL] [Abstract][Full Text] [Related]
11. Nanomicelle drug with acid-triggered doxorubicin release and enhanced cellular uptake ability based on mPEG-graft-poly(N-(2-aminoethyl)-L-aspartamide)-hexahydrophthalic acid copolymers.
Cao L; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
J Biomater Appl; 2018 Jan; 32(6):826-838. PubMed ID: 29132238
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin delivery via magnetic nanomicelles comprising from reduction-responsive poly(ethylene glycol)‑b‑poly(ε‑caprolactone) (PEG-SS-PCL) and loaded with superparamagnetic iron oxide (SPIO) nanoparticles: Preparation, characterization and simulation.
Mousavi SD; Maghsoodi F; Panahandeh F; Yazdian-Robati R; Reisi-Vanani A; Tafaghodi M
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():631-643. PubMed ID: 30184790
[TBL] [Abstract][Full Text] [Related]
14. Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues.
Huang HY; Chen LQ; Sun W; Du HH; Dong S; Ahmed AMQ; Cao D; Cui JH; Zhang Y; Cao QR
Theranostics; 2021; 11(2):906-924. PubMed ID: 33391512
[No Abstract] [Full Text] [Related]
15. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.
Xu M; Zhang CY; Wu J; Zhou H; Bai R; Shen Z; Deng F; Liu Y; Liu J
ACS Appl Mater Interfaces; 2019 Feb; 11(6):5701-5713. PubMed ID: 30644711
[TBL] [Abstract][Full Text] [Related]
16. Poly(ethylene glycol) shell-sheddable magnetic nanomicelle as the carrier of doxorubicin with enhanced cellular uptake.
Yu J; Li X; Luo Y; Lu W; Huang J; Liu S
Colloids Surf B Biointerfaces; 2013 Jul; 107():213-9. PubMed ID: 23502044
[TBL] [Abstract][Full Text] [Related]
17. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
[TBL] [Abstract][Full Text] [Related]
18. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS
J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818
[TBL] [Abstract][Full Text] [Related]
19. Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity.
Song YF; Liu DZ; Cheng Y; Liu M; Ye WL; Zhang BL; Liu XY; Zhou SY
Sci Rep; 2015 Nov; 5():16125. PubMed ID: 26530454
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin encapsulated in micelles enhances radiosensitivity in doxorubicin-resistant tumor cells.
Xu W; Han M; Diao Y; Pan T; Ge W; Liu H; He H; Jiang H; Zheng S; Zhang S; Gao J; Wei Q
Discov Med; 2014 Oct; 18(99):169-77. PubMed ID: 25336030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
